Fibromyalgia

Evidence Lacking for Most Fibromyalgia Therapies

By

Cassandra Pardini, PharmD

To assess the effectiveness of these therapies on pain reduction and quality of life improvement, study authors searched various databases for randomized or quasi-randomized clinical trials that evaluated these outcomes in fibromyalgia patients.

Updates on Diagnosis and Clinical Management of Fibromyalgia

Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, sleep disturbance, fatigue.

Negligible Effect of Small-Fiber Pathology on Fibromyalgia Symptoms

Researchers sought to determine whether small-fiber pathology has any clinically important effect on somatosensory system function.

Evaluating Intramuscular Pressure in Patients With Fibromyalgia

Researchers sought to evaluate the level of muscle tenderness and intramuscular pressure in the trapezius muscle of patients with fibromyalgia syndrome in comparison to controls.

Examining National Trends in Opioid Use Disorder Hospitalizations in Common Musculoskeletal Diseases

Researchers evaluated opioid use disorder hospitalizations and associated healthcare utilization outcomes in patients with common musculoskeletal diseases.

Fibromyalgia in Psoriatic Arthritis Associated With Sleep Disturbances and Poor Quality of Life

Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.

Substantial Agreement Between Classification Criteria for Fibromyalgia, With ACR 2011 Criteria Performing Best

Researchers compared the 3 diagnostic criteria and assessed the performance of an additional set of criteria in the diagnosis of fibromyalgia.

Duloxetine Approved for Pediatric Patients With Fibromyalgia

The FDA has expanded the approval of Cymbalta to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.

Fibromyalgia and Widespread Pain Weakly Associated With Mortality

Researchers investigated the association of fibromyalgia and widespread pain with mortality.

Comorbid Fibromyalgia Interferes With Disease Activity, Biologic Therapy Response in Inflammatory Rheumatic Diseases

According to the investigators, when managing patients with inflammatory rheumatic conditions in daily clinical practice, clinicians must assess signs and symptoms of fibromyalgia.

Improved Clinical Outcomes With 4 Weeks of Active TENS in Fibromyalgia

Four weeks of active transcutaneous electrical nerve stimulation (TENS) results in significant improvement in movement-evoked pain and other clinical outcomes compared with placebo-TENS or no TENS.